BioSpace News Archive

Agreement Includes Products, Technology and Manufacturing Assets in Brazil, India & South Africa

Medial EarlySign™ (earlysign.com), a leader in machine learning-based solutions to aid in early detection and prevention of high-burden diseases, today announced it is partnering with Geisinger and its Steele Institute for Health Innovation to develop and deploy a suite of machine learning-based solutions to identify individuals at risk of a range of chronic and high-burden diseases.

With best-in-class technology and award-winning customer service, Rectangle Health works with 50,000-plus healthcare providers in the U.S., reliably processing over $5 billion annually in patient payments.

Rennie will lead sales efforts across the region and focus on accelerating the telemedicine leader’s global revenue growth.

Revenue cycle departments at diagnostics labs face unique issues when it comes to managing increasingly complex prior authorization, eligibility and benefits verification, and patient financial responsibility requirements.

Funding for Sheridan College will help strengthen local economy and train the next generation

Purdue Pharma is pleased to announce that AKYNZEO® Oral is now reimbursed by the Ontario Public Drug Program and the Régie de l’assurance maladie du Québec and by the Non-Insured Health Benefits program for the prevention of chemotherapy induced nausea and vomiting.

Proteintech, the benchmark in antibodies and proteins, welcomes Frank Schestag, PhD, as Commercial Director.

American Regent today announced the introduction of Selenious Acid Injection, USP.

$1 million grant partnership will expand the number of care providers to engage more than 250 patients with substance abuse addiction per year